Results 331 to 340 of about 498,608 (348)

Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia

Lancet, The, 2011
Jill Janette Freda Belch, Lars Norgren
exaly  

Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial

Lancet, The, 2002
R David Anderson, Brian H Annex, Robert Jay Lederman   +2 more
exaly  

Fibroblast Growth Factor 2

2008
openaire   +1 more source

Randomised placebo-controlled trial of use of topical recombinant bovine basic fibroblast growth factor for second-degree burns

Lancet, The, 1998
Xiaobing Fu
exaly  

Fibroblast Growth Factor 2

2011
openaire   +1 more source

Prevalence of Pro250Arg mutation of fibroblast growth factor receptor 3 in coronal craniosynostosis

Lancet, The, 1997
Donna M Mcdonald-Mcginn
exaly  

Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial

Lancet, The, 2018
Arun J Sanyal, Brent A Neuschwander-Tetri, Rohit Loomba   +2 more
exaly  

Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis

New England Journal of Medicine, 2008
Orlando M Gutiérrez, Michael Mannstadt, Tamara Isakova   +2 more
exaly  

Fibroblast Growth Factor 23 in Oncogenic Osteomalacia and X-Linked Hypophosphatemia

New England Journal of Medicine, 2003
Yasuo Imanishi, Geeta Hampson, Michael J Econs   +2 more
exaly  

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Coelho Barata, Brian I Rini
exaly